Cxbladder is a suite of non-invasive genomic urine tests optimised for the risk stratification and rule out of urothelial cancer in patients presenting with haematuria and those being monitored for recurrent disease. Cxbladder tests allow you to prioritise your clinical resources on those who need it the most, while delivering the best patient experience possible.